Harrington Discovery Institute
Showing of 50 results
The Oxford-Harrington Rare Disease Centre (OHC) Announces Inaugural 2024 Rare Disease Scholar Award Recipients
10 scientists have been selected for OHC’s first annual award to advance academic discoveries into clinical practice for rare diseases.
Former UK Prime Minister David Cameron Joins Oxford-Harrington Rare Disease Centre (OHC) as Chair of its Advisory Council
Lord Cameron will lead international efforts to drive the OHC’s mission of delivering 40 new therapies for rare diseases into clinical trials over the next ten years.
Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine Open Call for 2025 Harrington-MSTP Scholar Award
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines.
New Study Shows that Chronic Neurodegeneration can be Prevented after Traumatic Brain Injury
University Hospitals and Case Western Reserve University research team reports a novel treatment after traumatic brain injury that prevents progression to chronic neurodegeneration.
Nominations Open for 12th Annual International Harrington Prize for Innovation in Medicine
Harrington Discovery Institute and the American Society for Clinical Investigation seek nominations to recognize an outstanding achievement by a physician-scientist.
Researchers Identify Potential Therapeutic Target for Management of Thirst Disorders
University Hospitals and Case Western Reserve University team show cerebellum is a thirst-modulating brain center.
The Oxford-Harrington Rare Disease Centre Announces Newly Funded Grant Award Programs to Develop New Therapies for Friedreich’s Ataxia
Philanthropic donation of up to £650,000 (approx. $823,000 USD) will enable the launch of two new grant award programs to support the research and development of greatly needed therapeutics for Friedreich’s Ataxia (FA).
Harrington Discovery Institute Announces 2024 Scholar-Innovator Award Recipients
Ten physician-scientists have been selected for drug development grant to advance discoveries into the clinic.